Emily
Editor, Senior Moderator
https://www.aljazeera.com/news/2022...zbekistan-linked-18-deaths-to-its-cough-syrup
Indian pharma under scrutiny again after 18 Uzbek child deaths
Among the world’s biggest drug exporters, India is investigating the firm whose cough syrup has been linked to the deaths.
29 Dec 2022
India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces.
In a statement on Thursday, India’s health ministry said the Central Drugs Standard Control Organisation (CDSCO) — the country’s drug regulatory authority — was communicating with its counterpart in Uzbekistan over the incident.
Uzbekistan’s health ministry had said in a statement on Wednesday that the children had died after consuming a medicinal syrup, Dok-1 Max, manufactured by Indian drug maker Marion Biotech Pvt Ltd. It said preliminary tests had showed that the syrup contained ethylene glycol, a toxic substance that has been linked to child deaths previously too.
“Immediately on receipt of the information, joint inspection of the Noida facility of the manufacturer, Marion Biotech, was carried out by Uttar Pradesh Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report,” the Indian government said in its statement on Thursday. Noida is a suburb of capital New Delhi and sits in the northern state of Uttar Pradesh. The Indian ministry said samples of the cough syrup had been taken for testing...
Indian pharma under scrutiny again after 18 Uzbek child deaths
Among the world’s biggest drug exporters, India is investigating the firm whose cough syrup has been linked to the deaths.
29 Dec 2022
India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces.
In a statement on Thursday, India’s health ministry said the Central Drugs Standard Control Organisation (CDSCO) — the country’s drug regulatory authority — was communicating with its counterpart in Uzbekistan over the incident.
Uzbekistan’s health ministry had said in a statement on Wednesday that the children had died after consuming a medicinal syrup, Dok-1 Max, manufactured by Indian drug maker Marion Biotech Pvt Ltd. It said preliminary tests had showed that the syrup contained ethylene glycol, a toxic substance that has been linked to child deaths previously too.
“Immediately on receipt of the information, joint inspection of the Noida facility of the manufacturer, Marion Biotech, was carried out by Uttar Pradesh Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report,” the Indian government said in its statement on Thursday. Noida is a suburb of capital New Delhi and sits in the northern state of Uttar Pradesh. The Indian ministry said samples of the cough syrup had been taken for testing...